Frontlight ResearchEarly access
Kidney cancer trials in Japan
8 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Akita, Asahikawa, Fukuoka, Hidaka, Hiroshima, Kobe, Kumamoto, Kurume, Matsuyama, Nagoya, Nankoku, Niigata, Okayama, Osaka, Sapporo, Shinjuku, Tokyo, Yokohama
- Age
- 18 years and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Fukuoka, Kobe, Koto-ku, Niigata, Shiwa-gun Yahaba-cho, Toyoma
- Age
- 18 years and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - Phase 1/2Taking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- Chūōku, Kashiwa
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - Phase 1/2Taking peopleSymbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Where
- Fukuoka, Shinjuku-ku, Suita, Yamagata, Yokohama
- Age
- 18 years and over
- People
- 224 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227415 · EU 2025-523524-53-00 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Kashiwa
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Taking peopleStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Where
- Chuo-ku, Wakayama
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00 - No phaseTaking peopleAbscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma
- Where
- Chūō
- Age
- 18 years and over
- People
- 145
- Run by
- Zhe Chen
See details and how to joinNCT07240610 - No phaseNot yet taking people in JapanInternational REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
- Where
- Tokyo
- Age
- 18 years and over
- People
- 10,000 worldwide
- Run by
- Azienda Ospedaliero-Universitaria Careggi
See details and how to joinNCT05363657